Correction : Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
Copyright: © 2020 Qu et al..
[This corrects the article DOI: 10.18632/oncotarget.18150.].
| Errataetall: |
ErratumFor: Oncotarget. 2017 May 24;8(46):81285-81294. - PMID 29113387 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Oncotarget - 11(2020), 16 vom: 21. Apr., Seite 1474-1477 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Qu, Lihui [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 17.09.2020 published: Electronic-eCollection ErratumFor: Oncotarget. 2017 May 24;8(46):81285-81294. - PMID 29113387 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18632/oncotarget.27561 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309466105 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309466105 | ||
| 003 | DE-627 | ||
| 005 | 20231225133956.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.27561 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309466105 | ||
| 035 | |a (NLM)32363004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Qu, Lihui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Oncotarget. 2017 May 24;8(46):81285-81294. - PMID 29113387 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2020 Qu et al. | ||
| 520 | |a [This corrects the article DOI: 10.18632/oncotarget.18150.] | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Lu, Yingying |e verfasserin |4 aut | |
| 700 | 1 | |a Ying, Meike |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Bingjue |e verfasserin |4 aut | |
| 700 | 1 | |a Weng, Chunhua |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Zhoutao |e verfasserin |4 aut | |
| 700 | 1 | |a Liang, Ludan |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Chuan |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Xian |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Shi |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yucheng |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Xiujin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Qin |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Zhimin |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Jianyong |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Weiqiang |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Hang |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Junwen |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jianghua |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Hongfeng |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 11(2020), 16 vom: 21. Apr., Seite 1474-1477 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g number:16 |g day:21 |g month:04 |g pages:1474-1477 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.27561 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |e 16 |b 21 |c 04 |h 1474-1477 | ||